background: Diminished ovarian reserve (DOR) is a heterogeneous disorder causing infertility, characterized by a decreased number of oocytes, the genetic cause of which is still unknown.
Introduction
Diminished ovarian reserve (DOR) is a primary infertility disorder characterized by a reduction in the number and/or quality of oocytes, usually accompanied by high follicle-stimulating hormone (FSH) levels and regular menses (Broekmans et al., 2007) . Generally, diagnosing DOR is problematic because of the absence of obvious clinical signs and as a consequence, proper reproductive counselling is often delayed. DOR aetiology factors are multiple and different, such as genetic factors, ageing, autoimmune disorders, adrenal gland impairment factors and iatrogenic causes, e.g. due to radiation or chemotherapy. The genetic determinants of DOR are still unknown.
Most DOR patients, mainly sporadic, have been described in association with structural chromosomal rearrangements (Kuo and Guo, 2004; Kummer et al., 2009) , often involving the X chromosome. Indeed, the DOR disease has been reported with a significantly high incidence (44.4%) in females carrying X chromosome mosaicisms (Kuo and Guo, 2004) . Furthermore, DOR has been described as a feature of Turner syndrome (Khastgir et al., 1997; Kuo and Guo, 2004) , or as a pathology recurring in families presenting other primary infertilities, such as premature ovarian failure (POF; Kummer et al., 2009) or early menopause (EM; Nikolaou et al., 2002; Lawson et al., 2003) . Both conditions, POF and EM, defined as gonad dysgenesis with a complete cessation of ovarian function or an intermittent follicle maturation failure, respectively, are often present in association with specific Xp or Xq deletions or with balanced X;autosome translocations (Therman et al., 1990; Vegetti et al., 2000; Fimiani et al., 2006; Rizzolio et al., 2006; Ferreira et al., 2010) .
These X-linked alterations, POF and EM, do not generally interrupt genes but are clustered in two loci, named POF locus 1 (POF1) and POF locus 2 (POF2). The POF1 region limits are not generally accepted, as some authors define the region as Xq23-q27, whereas others define it from Xq26 to Xq28 (Tharapel et al., 1993; Fimiani et al., 2006; Ferreira et al., 2010) . In several cases, an identical POF1 deletion is present in association with POF or EM in two or even three generations of the same family (Eggermann et al., 2005; Fimiani et al., 2006; Rizzolio et al., 2006) . The POF2 region is well-established between Xq13.3 and Xq21 (Schlessinger et al., 2002; Toniolo and Rizzolio, 2007) and POF translocation mapping has revealed interruptions in different genes, such as in Diaphanous homolog 2 Drosophila (DIAPH2) and POF1B . In the POF1 locus no disease gene has been ascertained, although the association between FMR1 premutations and the POF disease has suggested that the FMR1 gene acts as a risk factor for the POF (Murray, 2000; Miano et al., 2007) and recently for the DOR (Gleicher and Barad, 2010) pathogenesis. Mapping studies in cases of balanced X;autosome infertility-related translocations have found that ovarian function undoubtedly is affected by altered genomic sequences in Xq (Rizzolio et al., 2006 (Rizzolio et al., , 2008 . Unbalanced X;autosome translocations are rare. Males often have congenital anomalies and mental retardation and females may or may not have POF/infertility and mental retardation (Chen et al., 2006; Gupta et al., 2006; Stankiewicz et al., 2006; Guo et al., 2009; Jezela-Stanek et al., 2011) . Recently, array technology has been used to analyse several POF patients characterizing X alterations and copy number variations (Han et al., 2006; Tachdjian et al., 2008; Aboura et al., 2009; Bertini et al., 2010; Dudding et al., 2010; Giacomozzi et al., 2010; Quilter et al., 2010) .
The majority of the structural abnormalities that involve the X chromosome are maternally derived (Monroy et al., 2002) . They occur during oogenesis, often at the first (MI) meiotic division because of the prolonged quiescent state of the oocytes (Hassold et al., 2007; Martin, 2008) , and quite rarely in the second meiotic division (MII) (Martin, 2008) . In some cases, women can be carriers of silent rearrangements (Fusco et al., 2009) . In this respect, mispairing and recombination could generate differences in the breakpoint extension and thus different induced-phenotypes (Fantes et al., 2008) . Intraand inter-phenotypic heterogeneity is a crucial aspect of many human diseases and this could be due to secondary factors, such as allelic variations, additional genomic alterations or epigenetic modifications, which could modify the expressivity of such rearrangements (Rossetti et al., 2004; Fimiani et al., 2006) .
We here report the genetic and molecular characterization of a familial unbalanced X;autosome translocation der(X)t(X;18)(q27;q22) associated with DOR, presenting incomplete penetrance. Loss and gain of the genomic segments have been identified by aCGH and located by fluorescence in situ hybridization (FISH). Using short tandem repeat polymorphism (STR) genotyping and real-time PCR, we have refined the breakpoint regions revealing that the DOR rearrangement is maternally derived. In silico nucleotide sequence investigation has established that the break sites in both the X and 18 chromosomes are embedded in long interspersed nuclear element (LINE) sequences that could mediate the outline of the derivative X chromosome. Blocks of LINE elements are present around the distal junctions, which could trigger chromosomal mispairing and unequal homologous recombination during meiosis. In the lymphocytes, X-inactivation studies have revealed skewed X inactivation of the derived X chromosome that might mediate the variable expression of the phenotypes, fully rescued in the asymptomatic mother and attenuated in the daughter with DOR.
Materials and Methods

Chromosomal and FISH analyses
Peripheral blood samples were collected and cultured. Phytohaemagglutinin-stimulated lymphocytes were harvested from the proband (III:3) and her mother (II:4). Metaphase chromosome spreads were prepared and chromosome analysis was performed using the standard protocols. FISH analysis was performed using a commercially available centromeric probe for the X chromosome and a subtelomeric probe for the 18q chromosome (Abbott).
Whole genome aCGH
Genomic DNA was extracted from peripheral blood cells from the patient with DOR (III:3) and her mother (II:4). aCGH was performed using the Agilent human 2 × 105 K whole genome microarray (designed by Signature Genomics Laboratory) that contains 105 000 oligonucleotide (60mer) probes with an average spatial resolution of 35 kb across the genome (Agilent Technologies, CA, USA). DNA samples were analysed in dye swap according to the manufacturer's protocol (www.genomics. agilent.com). Hybridization data were analysed by software provided by Agilent Technologies.
Real-time PCR experimental design and output data analysis
We designed two panels of primer pairs for the real-time PCR experiments: Panel_chX with 10 primer pairs P1chX, P2chX, P3chX, 88chX, 137chX, 80FMR1, 204FMR1, 109FMR1, P6chX and P7chX, covered the region from the 139 695 697 to 151 788 281 bp of the X chromosome (UCSC Genome Browser March 2006 Freeze); and Panel_18q with 13 primer pairs P5ch18, P6ch18, P7ch18, P8ch18, P9ch18, P10ch18, P11ch18, 213ch18, 233ch18, 225ch18, 106ch18, 111ch18 and P12ch18, covered the region from the 61 871 343 to 64 664 809 bp of chromosome 18 (UCSC Genome Browser March 2006 Freeze). The sequences of the primers, designed using Primer express 3.0 software (Applied Biosystems, Lennik, Belgium), are available upon request. Each amplification product (70-100 bp) was mapped in the unrepeated region and they were Unbalanced X;18 translocation in a female with DOR interspersed within a range of 800 bp up to 8 Mb. Real-time PCR assays were carried out on the Applied Biosystem 7900HT system by using SYBR Green as a fluorescent reporter (Power SYBR Green PCR Master Mix, Applied Biosystem). All quantifications were normalized to the endogenous gene control beta-2-microglobulin (B2M gene, GenBank NM_004048), as described in Fusco et al. (2009) . A dissociation curve analysis was performed at the end of the amplification process in order to verify the specificity of the PCR products (Fusco et al., 2006) . The DNA copy number was determined as 2 2DDCt for each individual under study versus a female control (XX) and a male control (XY) to study the X monosomy, and a diploid healthy control (18/18) and an 18 trisomy (18/18/18) sample to characterize the 18 trisomy. For each X amplicon, a specific profile was obtained according to the predicted fragment dosage that is bi-allelic in the wild type XX and monoallelic in the wild type XY; for each 18 amplicon a dosage profile was obtained that is bi-allelic in the wild type 18/18 and tri-allelic in the 18/18/18 DNA. Standard deviations for the C t of the technical replicates were calculated (Fusco et al., 2006) . Statistically significant mean differences between each sample in terms of DNA content were calculated by the t-test method. Differences were considered to be statistically significant at the 95% confidence level (P , 0.05).
Microsatellite genotyping and DNA repeat search
Xq27-.qter and 18q22-.qter polymorphic markers were genotyped in the family under study. Genomic DNA was isolated from EDTA anti-coagulated blood by a salting out procedure. We used eight STRs DXS1192, DXS1205, DXS8106, DXS8069, DXS1684, DXS8061, DXS15 and DXS1073, for the genotyping of the Xq27 monosomy; and six STRs, D18S51, D18S392, D18S483, D18S857, D18S1373 and D18S488, for the 18q22 duplication. Oligonucleotide primer sequences were obtained from a public databank and the respective forward primer was 5 ′ end-labelled with fluorochromes. Fluorescence-labelled amplification products were evaluated as different peaks or alleles varying in intensity (peak area) and size (in base pairs) after capillary electrophoresis in a Genetic Analyzer. As the amount of DNA produced is proportional to the quantity of the initial target, a trisomy can be presented either in a tri-allelic form with a relative peak area dose near to 1:1:1 or in a di-allelic form (2:1); while a monosomy can be presented in a monoallelic form with a relative peak area dose near to 1:0. A DNA sample obtained from an embryo carrying a full 18 trisomy was used as a control for the partial 18 trisomy study and a DNA sample of a healthy male was used for the Xq monosomy study. Map position information on the STRs was obtained from the University of California-Santa Cruz genome browser (UCSC March 2006 Freeze; http://genome.ucsc. edu/). Parental haplotypes were phased on the basis of the most parsimonious explanation of the observed genotypes. PCR conditions were maintained and detection methods were carried out as previously described (Fimiani et al., 2006) . A web-based sequence-analysis program (RepeatMasker; www.repeatmasker.org/) was used to investigate the genomic segments falling within each breakpoint, including 2 Mb surrounding the Xq27 breakpoint (from 141.85 to 148.85 Mb) and the 18q22 breakpoint (from 63.14 to 66.09 Mb).
Androgen receptor assay and late-replication analysis
For the HUMan Androgen Receptor Assay (HUMARA) locus test, we used fluorescently labelled primers flanking a sequence containing a highly polymorphic CAG repeat and two HpaII sites in the AR gene (Allen et al., 1992; Fimiani et al., 2006) . The X chromosome inactivation (XCI) assay was performed in the proband (III:3), her sister (III:4) and her mother (II:4) using a modified protocol as reported elsewhere (Allen et al., 1992) . In a sample obtained from the female control, if the X chromosome is subject to random inactivation, both alleles should be present, whereas in the case of skewed inactivation, only the allele that is preferentially inactivated will be amplified. XCI degree threshold patterns are classified as random (XCI ≤ 70%), non-random (70% ≤ XCI ≤ 80%) and skewed (.80%).
Late-replicating X was detected as previously described (Jacobs and Migeon, 1989) . A lymphoblastoid cell line from the patient with DOR was prepared by EBV transformation. Lymphoblastoid cells were exposed to BrdU for 5 h prior to colcemid addition. Incorporated BrdU was then immunolabelled using mouse monoclonal anti-BrdU, detected with anti-mouse IgG -FITC, post-fixed in 4% paraformaldehyde and hybridized with the whole chromosome painting 18 (wcp18, Vysis). Probe preparation, hybridization and post-hybridization washes were performed according to manufacturer's instructions. Slides were counterstained with DAPI/Antifade (Vector). The images were captured using the Olympus BX51 fluorescent microscope and analysed by the Cytovysion vers.3.7 software.
Results
Case
A three generation family (Fig. 1A ) was brought to our attention through the propositus (III:3), a 32-year-old female with a known reduced number of antral follicles consistent with a diagnosis of DOR. The propositus (III:3) is the first child of unrelated parents. She was born and raised in Argentina but she is of European descent because her father is Italian and her mother is Basque. She did not show any phenotypic abnormalities or clinical problems beyond her infertility, for which she had failed multiple IUI attempts, three IVF cycles and two donor oocyte IVF cycles. Her physical examination was unremarkable. She had menarche at 14 years of age and is regularly menstruating. She is of normal height and normal weight and has none of the Turner syndrome traits. By transvaginal ultrasound, she showed a low ovarian volume and an antral follicle count of ,11, resulting in her DOR diagnosis (Mol et al., 2006) . The FSH and LH levels were normal and no signs of premature menopause were detected. Tubal patency on hysterosalpingogram and routine laboratory tests, including complete blood count and electrolyte and thyroid function studies were unremarkable. DOR aetiology factors such as autoimmune disorders, adrenal gland impairment, iatrogenic due to radiation or chemotherapy were excluded. Initial investigations demonstrated a normal semen analysis for her partner. The proband with DOR was referred to the Genetics Clinic at Kaiser Permanente because she had abnormal results for the FMR1 gene as a part of her DOR analysis, testing for a Fragile X premutation as the cause of her premature ovarian dysfunction. PCR analysis revealed one normal allele with 30 CGG repeats of the FMR1 gene. The Southern blot showed the presence of the unmethylated band of 2.8 kb corresponding to the normal active FMR1 allele; however, the expected methylated 5.2 kb band corresponding to the normal inactive FMR1 allele was not observed (data not shown). This abnormal Fragile X DNA result suggested that she could have a rearrangement or deletion near the FMR1 gene, which maps to Xq27.3 (from 146 801 201 to 146 822 898 bp; NCBI36/hg18 UCSC March; 2006). The mother (II:4) was fertile. She had menarche at 13 years and had another daughter (III:4) and twin sons (III:5 and III:6). At the age of 47, she entered menopause. The grandmother (I:2) was fertile, had four children and entered menopause at 52 years. The mother (II:4), the grandmother (I:2) and the sister (III:4) underwent complete clinical assessment, including medical evaluation for DOR. The diagnosis of POF or DOR was excluded. After extensive familial counselling, no other cases of DOR or ovarian failure or spontaneous miscarriage were reported in the family. All willing family members provided written informed consent under protocols approved by the Declaration of Helsinki, either directly or through their physicians.
Identification of the der(X)t(X;18) (q27;q22) rearrangement aCGH analysis identified two unique genomic imbalances both in the proband and her mother (II:4): a deletion of Xq27.2-qter at genomic position 141 297 887-155 270 560 (Fig. 1B and C) and a duplication of 18q22.1-qter at genomic position 64 551 532-78 077 248 ( Fig. 1D and E cytogenetic analysis did not reveal any additional rearrangement. FISH analysis with DNA probes for the X centromere and 18q subtelomeric regions confirmed the unbalanced X;18 translocation (Supplementary data, Fig. S1 ). aCGH (Fig. 1B -E ) and FISH analysis (data not shown) revealed the same rearrangement also in the proband's mother (II:4). No additional chromosomal differences between the two investigated females were identified. However, we were unable to perform complete cytogenetic and aCGH studies on the grandmother and therefore it is unclear whether or not she carries a t(X;18) translocation (balanced or unbalanced).
Molecular characterization of the Xq27-qter and 18q22-qter rearrangements Real-time PCR was performed to define the breakpoint limits. The DOR proband (III:3) showed the genomic chX probe set with a wild type bi-allelic dosage from P1chX (139 695 697 bp) up to P3chX (141 025 731 bp) and with one less copy than the wild type female in 88chX (146 799 731 bp) up to P7chX (151 788 281 bp) (Supplementary data, Table SI and Fig. S2 ). In the mother of the proband with DOR, we obtained a genomic chX probe set with a similar trend (data not shown). For the 18q22 duplication study, we established the copy number of 17 primer pairs that amplified 13 fragments located in the 18q21-qter interval. We fixed the genomic profile data in two control DNA samples representing the wild type bi-allelic genotype for chromosome 18 (18/18) and the abnormal tri-allelic genotype of chromosome 18 (18/18/18; Supplementary data, Table SI and Fig. S2 ). The genomic ch18 set probe with the bi-allelic wild type profile from P5ch18 (61 871 343 bp) up to P11ch18 (64 584 818 bp) with an additional copy compared with the bi-allelic wild type from the probe 213ch18 (64 601 567 bp) up to P12ch18 (64 664 716 bp) was found in the DOR proband (III:3) and her mother (II:2) (Supplementary data, Table SI and Fig. S2 ).
Haplotype mapping of the Xq27->qter and 18q22->qter regions for the parental-origin study
The genotyping analysis confirmed the presence of a X2_d haplotype with a monoallelic asset for five STRs, DXS8069, DXS1684, DXS8061, DXS15 and DXS1073, in the mother (II:4) that was transmitted, identical by descent, to the DOR patient (III:3) (Supplementary data, Fig. S3 ). Consequently, the upper boundary of the Xq monosomy was marked by DXS8106, located in the Xq27.3 band, at nucleotide position 141 911 701 bp (Homo sapiens UCSC hg18-2006). As expected, the healthy sister (III:4) and her brother (III:6) carried a normal dosage of STR haplotypes (X1 and X3 in III:4; and X1 in III:6) in accordance with XX and XY karyotypes, respectively (Supplementary data, Fig. S3 ). At the same time, we genotyped, as described above, six specific polymorphic markers covering the 18q critical area (Supplementary data, Fig.  S3 ). In the two females under study, the proband's mother (II:4) and the proband with DOR (III:3), we established a normal bi-allelic dosage for D18S51, D18S392, D18S483 and D18S857; and a tri-allelic dosage, with 1:1:1 ratio or 2:1 ratio, of two distal markers D18S1373 and D18S488, segregating with the common A3_d haplotype and transmitted from the mother (II:4) to the daughter (III:3). Consequently, the upper boundary of the 18q22 duplication is marked by D18S857, located in the 18q22.1 band, fixing the upper limit of the trisomic region at nucleotide position 62 228 760 bp (Homo sapiens UCSC hg18-2006). These findings indicate that the X/18 rearrangement (genotype a) was maternally transmitted from the fertile mother to the DOR daughter (genotype c) though the IBD haplotypes, X2_d and A3_d. Its origin is unknown but it could have been inherited as a silent rearrangement from the asymptomatic grandmother or alternatively it could have been generated in her germline as a de novo alteration to the female II:4 and then transmitted to her daughter III:3.
Mapping of the Xq27 and 18q22 breakpoints
Combining the graphical representation of the fold change values obtained for all X chromosome probes used and the genotype data of STR haplotype X2_d, we mapped the critical region of the Xq breakpoint, named Xq27bkp, between the marker DXS8106 and 88chX, both located in the Xq27.3 band (Fig. 2A) . Assuming that the upper boundary of the Xq27.3 breakpoint region corresponds to the DXS8106 location at 141 911 701 bp and the distal position of Xqter at 155 270 560 bp, we estimated that the mother and her daughter carried an identical segmental Xq27-qter deletion spanning more or less 13.3 Mb, with a critical mapping gap of 4.8 Mb (Fig. 2A) . Xq27bkp falls within a gene-poor region containing six genes with a ubiquitous expression ( Fig. 2A) : Sperm Protein Associated with the Nucleus on the X chromosome N3 (SPANXN3), Slitand Ntrk-like family member 4 (SLITRK4), ubiquitin-conjugating enzyme E2N-like (UBE2NL), Sperm Protein Associated with the Nucleus on the X chromosome N1 (SPANXN1), Slit-and Ntrk-like family member 2 (SLITRK2) and the gene CXorf51 coding for the hypothetical protein LOC100129239. The proximal limit is located between the SPANXN4 and SPANXN3 genes and the distal limit between the genes CXorf51 and FMR1. Additional probes, designed on the CGH array output, were tentatively used to refine more accurately the X chromosome break, but no informative real-time probes were found to restrict the Xq27.3 site.
By analysing the graph of the fold change values of the entire Panel_ch18, we inferred that the 18 breakpoint site, named 18q22bkp, is located in 18q22.1 in a locus of 16 kb. Therefore, assuming 78 077 248 bp as the distal position of 18qter, the mother and the DOR patient carry an identical segmental 18 duplication spanning more or less 13.4 Mb (Fig. 2B) . The 18q22bkp locus is delimited by the proximal marker P11ch18, which maps downstream to Thioredoxin domain containing 10 (TMX3) gene, and by the distal marker 213ch18, which falls within Coiled-coil domain containing 102B (CCDC102B) gene.
In-silico analysis of the genomic context of Xq27_bkp and 18q22_bkp
We calculated interspersed repetitive element densities within the unique sequence of the Xq27 and 18q22 critical loci (4.8 Mb and 16 kb, respectively). The long interspersed nuclear element (LINE), short interspersed nuclear element and long terminal repeat contents of the proximal and distal surrounding areas of Xq27bkp and of 18q22bkp were calculated by in-silico analysis. Our results show that in both regions, LINE is the most abundant repeat class covering 35% of the Xq27bkp locus and 25% of the 18q22bkp locus (Supplementary data, Fig. S4 ).
Unbalanced X;18 translocation in a female with DOR
X inactivation status of the der(X) chromosome
We wondered if a non-random XCI pattern was associated with the DOR disease. The CpG methylation status of the AR gene, one of the epigenetic markers of the Xq12 region, was established in the proband (III:3), in the healthy sister (III:4) and in the asymptomatic mother (II:4). We found that III:3 and II:4 were fully skewed (XCI degree threshold ¼ 100%) for the same AR allele (Allele1, length 278 bp; Supplementary data, Table SII) . On the contrary, the healthy sister, carrying a normal 46,XX karyotype (data not shown) showed a random XCI profile (XCI degree threshold Allele1 ¼ 60% and Allele2 ¼ 40%). To establish whether the der(X) or the normal X chromosome was skewed, we carried out a replication analysis on the EBV-transformed lymphocyte metaphases of the DOR patient. In 98 out of 100 analysed metaphases (98%), the der(X) chromosome was late-replicating (Fig. 3) . The translocated segment of 18q on the der(X) also showed a late-replication. From this analysis, we can infer that the irregular dosage of genes located on the duplicated 18q22-qter as well as on the deleted X chromosome could be silenced.
Discussion
In this paper, we have mapped a familial unbalanced X;18 translocation with a variable expressivity associated with DOR and we have located the DOR locus in the POF1 region. We assume that DOR is an intermediate condition between a normal reproductive physiology and EM and thus belongs to the X-linked ovarian failure spectrum, including POF and EM.
Variable expressivity and the POF/DOR locus
The relationship between the unbalanced X;autosome translocation der(X)t(X;18)(q27;q22) and the variable fertility phenotypes is the central aspect of this study. We have observed that an identical rearrangement der(X) is present in association with a fertile phenotype in the proband's mother but is linked to a DOR outcome in the proband. Secondary modifications such as epigenetic regulation may have a key role in der(X) expressivity. In both the fertile mother and the DOR proband, the tested skewing phenomena of the rearranged X chromosome could restore, at least in part, the unbalanced genetic make-up, fully silenced in the proband's mother and partially attenuated in the DOR proband. Generally, skewing is a mechanism characterizing the expression of an unbalanced X-autosome translocation as reported in several studies (Guo et al., 2009) . X inactivation is, therefore, a key determinant of the clinical phenotype of several X-linked diseases as reported in several reports (Prothero et al., 2009; Yang et al., 2011) . Discrepancies between X inactivation ratio and phenotype are not rare and can be due to gene disruption, position effect, complex micro-rearrangements and variable pattern of X inactivation in different tissues (Pegoraro et al., 1997; Yang et al., 2011) . However, in some cases the X inactivation centre spreads signals across the X chromosome through the X;autosome boundary resulting differently in various asymptomatic or attenuated phenotypes (Hall et al., 2002) .
Given that, which is the genomic region of der(X) crucial for fertility impairment in the DOR proband? First of all, in both the DOR female and her mother, there are no 18q duplication-related phenotypes, such as multiple severe malformations including congenital heart and neurological defects (Razavi-Encha et al., 1985) . Their phenotypes, instead, clearly correlate with the full inactivation of 18q22-qter duplication. In addition, no infertility gene or locus has been ascribed to the 18q22-qter region (Rizzolio et al., 2008) . Recently, a case of a female patient with primary amenorrhea and growth hormone deficiency has been reported to carry a balanced translocation involving the long arm of the X and 18 chromosomes, (X;18)(q22.3;18q23). In that case, the short stature was related to the 18q portion while ovarian disease was excluded, as it is not associated with the 18q portion but rather should be linked to the Xq POF region (Rizzolio et al., 2008) .
Regarding the Xq monosomy, our mapping analysis showed that the DOR deletion overlaps with the POF1 locus, located from Xq26 to Xq28 (Tharapel et al., 1993; Fimiani et al., 2006; Ferreira et al., 2010; Fig. 4) . The POF1 locus contains several genes but none of these are known to be involved in ovarian functions except for FMR1, a risk gene for the POF and DOR diseases (Murray, 2000; Miano et al., 2007; Gleicher and Barad, 2010) that in the DOR proband appears as a hemizygous locus because it is present in only one copy. It is worth noting that the genetic mechanism that produces Unbalanced X;18 translocation in a female with DOR X-linked infertility in POF, as well as in DOR, is unclear. One of the possible mechanisms, already proposed for X-linked POF (Ferreira et al., 2010) , might involve a gene dosage effect, such as the lack of expression of genes normally escaping X inactivation (haploinsufficiency). This is in line with the assumption that the distal region of the Xq plays a crucial role in the female reproduction physiology (Schlessinger et al., 2002; Fimiani et al., 2006) . Concerning the variable expressivity associated with the DOR der(X), one possible explanation could be a different timing of X-inactivation in germ cells or in granulosa cells determining a variability of fertility performances. Variable expression is a well-known phenomenon in diseases with a dominant mode of inheritance (Auber et al., 2009 ) and in familial infertility diseases linked to the POF1 locus (Rossetti et al., 2004; Fimiani et al., 2006) . For instance, we have already described an interstitial Xq26.2-q28 deletion associated with either EM or POF through two generations in the same family (Fimiani et al., 2006) , after a report by Rossetti et al. (2004) describing a terminal deletion of Xq28 in a fertile mother, transmitted to two daughters affected by POF. This variable expressivity raises the possibility that factors other than the Xq deletion might be involved in these infertility disorders, because, within the same family or in different families, women manifesting impaired reproductive performance may be either able to reproduce or completely infertile (Fimiani et al., 2006; Ferreira et al., 2010) .
Origin of the der(X)t(X;18)(q27;q22)
The origin of the unbalanced t(X;18)(q27;q22) is unknown. There are three possibilities: (1) the der(X) is produced as a de novo rearrangement occurring in the grandmother's germ-line; (2) the asymptomatic grandmother carries a balanced t(X;18) translocation and transmitted to her daughter (the proband's mother) through the unbalanced gamete der(X); or (3) the grandmother carries the same unbalanced t(X;18) translocation that was transmitted to her daughter. In both scenarios 2 and 3, the der(X) can be subsequently transmitted identically by descent (Xmder) from the mother (II:4) to her daughter (III:3). We were not able to identify the breakpoint sites and the exact nucleotide junction points precisely since they were located in regions with a high density of DNA repeat elements. In fact, the Xq27bkp and 18q22bkp regions show an accumulation of LINEs, which are the most common transposable elements of the human genome triggering mispairing and unequal crossing-over (Kazazian and Goodier, 2002; Cordaux and Batzer, 2009 ). The most probable consequences of the high LINE density at both breakpoints could be the induction of a local genomic instability and the generation of the X;18 rearrangement during the gametogenesis of the grandmother or alternatively in a previous generation. The Xq27-q28 band has already been recognized as having a high repeat density and high recombination frequency, indicating that it is a hot spot region for the generation of aberrant X recombination (Fimiani et al., 2006; Carvalho et al., 2009; Fusco et al., 2009 ) also in unbalanced translocations with different autosomal chromosomes (Caiulo et al., 1989; Yatsenko et al., 2004; Guo et al., 2009) . Similarly, the surrounding areas of the 18q22 breakpoint are full of unstable sequences spanning a cluster of breakpoints for balanced and unbalanced translocations (Boghosian-Sell et al., 1996; Cuker et al., 2004; Riegel et Furthermore, the 18q22 breakpoint coincides with the FRA18C region, an aphidicolin-sensitive fragile site (Debacker et al., 2007) .
Conclusions
We conclude that the DOR critical region maps to the POF1 locus and the phenotypic differences in fertility within the investigated family must be assigned to other genetic or environmental factors and not to the presence of different rearrangements. The manifestation of the derivative X chromosome could be mediated by the X-inactivation phenomenon, by the inheritance of a modifier genetic factor or by other environmental factors, such as those known to affect ovulation. However, establishing the details of the der(X) rearrangement is quite important for the genetic counselling of the family also in order to predict the effect in any descendents and to optimize the medical treatment of the infertility. Special attention is generally paid to Xq rearrangements in which secondary modifications, such as X inactivation, could modify the pathological outcomes and consequently the counselling given in these cases could be inadequate. Although a fertility prognosis with the DOR proband's gametes remains suboptimal, given the reduced ovarian reserve, for female offspring inheriting the unbalanced X;18 translocation, fertility outcomes would be variable, ranging from normal fertility to DOR, POF or mental retardation. In male offspring who inherit the unbalanced X;18 translocation this would be lethal or would have a severe affect given the complete lack of many Xq27-Xqter genes and the 18q22 trisomy. In the case presented here, the proband chose to pursue another donor oocyte IVF cycle, became pregnant and delivered a normal baby. Although it is conceivable to assume that the incomplete penetrance of der(X) might result in different fertility outcomes, we cannot exclude the possibility that other genomic alterations may contribute to the DOR condition in the proband, a hypothesis which merits a rigorous explanation after research into any additional and private mutations in the proband's genome. In this regard, personal genome studies could help to explain the phenotypic variability associated with the wide spectrum of familial and sporadic X-linked DOR/POF diseases and to identify the genetic determinants of the ovarian reserve physiology.
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